Insmed Inc - INSM - reported that the FDA has lifted the clinical hold previously placed on ARIKACE (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacteria lung disease.

Tags: INSM SLB BIOD Nasdaq:INSM NYSE:SLB Nasdaq:BIOD